37 results
424B3
SRZN
Surrozen Inc
8 Nov 23
Prospectus supplement
4:27pm
, is the first development candidate using our SWEETS technology which is designed to mimic the regenerative properties of the protein R-Spondin
424B3
SRZN
Surrozen Inc
9 Aug 23
Prospectus supplement
4:39pm
development candidate using Surrozen’s SWEETS technology which is designed to mimic the regenerative properties of the protein R-Spondin by enhancing Wnt
424B3
qefzvowdbhvg5of4
10 May 23
Prospectus supplement
4:47pm
424B3
k9mdzkebm5k7342iyq
7 Apr 23
Prospectus supplement
5:20pm
424B3
2l0cq 25n0t5
6 Apr 23
Prospectus supplement
5:15pm
POS AM
jkgwn4v0qtw8kq4u5u1
31 Mar 23
Prospectus update (post-effective amendment)
4:52pm
POS AM
9xi6 xkn5
31 Mar 23
Prospectus update (post-effective amendment)
9:09am
424B5
ng9bsygotklsz0n9j5
21 Dec 22
Prospectus supplement for primary offering
6:05am
S-3
uw5x7b694vov9
9 Dec 22
Shelf registration
5:31pm
424B3
r3se266kbzbv974z72d
15 Nov 22
Prospectus supplement
6:30am
424B3
68uat5 md
15 Nov 22
Prospectus supplement
6:30am
424B3
lf4 7k8q378d
24 Aug 22
Prospectus supplement
7:43pm
424B3
ajpfg5u3i5xkf4ty42e
23 Aug 22
Prospectus supplement
5:13pm